Z. Temesgen, C. Burger, J. Baker, C. Polk, C. Libertin, C. Kelley, VC Marconi, R. Orenstein, VM Catterson, W. Aronstein, C. Durrant, D. Chappell, O. Ahmed, G. Chappell, A. Badley
{"title":"Lenzilumab在新住院的Covid-19患者中的疗效和安全性:LIVE-AIR 3期随机双盲安慰剂对照试验的结果","authors":"Z. Temesgen, C. Burger, J. Baker, C. Polk, C. Libertin, C. Kelley, VC Marconi, R. Orenstein, VM Catterson, W. Aronstein, C. Durrant, D. Chappell, O. Ahmed, G. Chappell, A. Badley","doi":"10.1136/thorax-2021-btsabstracts.54","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":114929,"journal":{"name":"Developing treatments for COVID-19","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"S48 Lenzilumab efficacy and safety in newly hospitalized Covid-19 subjects: results from the LIVE-AIR phase 3 randomized double-blind placebo-controlled trial\",\"authors\":\"Z. Temesgen, C. Burger, J. Baker, C. Polk, C. Libertin, C. Kelley, VC Marconi, R. Orenstein, VM Catterson, W. Aronstein, C. Durrant, D. Chappell, O. Ahmed, G. Chappell, A. Badley\",\"doi\":\"10.1136/thorax-2021-btsabstracts.54\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":114929,\"journal\":{\"name\":\"Developing treatments for COVID-19\",\"volume\":\"12 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Developing treatments for COVID-19\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/thorax-2021-btsabstracts.54\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Developing treatments for COVID-19","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/thorax-2021-btsabstracts.54","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
S48 Lenzilumab efficacy and safety in newly hospitalized Covid-19 subjects: results from the LIVE-AIR phase 3 randomized double-blind placebo-controlled trial